STAA STAAR SURGICAL CO

Nasdaq staar.com


$ 26.69 $ 1.37 (5.41 %)    

Tuesday, 21-Oct-2025 15:59:55 EDT
QQQ $ 610.86 $ -0.16 (-0.03 %)
DIA $ 469.44 $ 2.20 (0.47 %)
SPY $ 671.43 $ -0.01 (0 %)
TLT $ 92.02 $ 0.45 (0.49 %)
GLD $ 379.46 $ -25.91 (-6.43 %)
$ 26.69
$ 25.26
$ 24.75 x 100
$ 26.99 x 9
$ 24.95 - $ 26.78
$ 13.50 - $ 32.00
1,570,875
na
1.32B
$ 1.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-27-2025 10-Q
2 05-07-2025 03-28-2025 10-Q
3 02-21-2025 12-27-2024 10-K
4 10-30-2024 09-27-2024 10-Q
5 08-07-2024 06-28-2024 10-Q
6 05-07-2024 03-29-2024 10-Q
7 02-27-2024 12-29-2023 10-K
8 11-06-2023 09-29-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-23-2023 12-30-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-10-2022 07-01-2022 10-Q
14 05-04-2022 04-01-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-03-2021 10-01-2021 10-Q
17 08-04-2021 07-02-2021 10-Q
18 05-05-2021 04-02-2021 10-Q
19 02-24-2021 01-01-2021 10-K
20 11-04-2020 10-02-2020 10-Q
21 08-05-2020 07-03-2020 10-Q
22 05-06-2020 04-03-2020 10-Q
23 02-26-2020 01-03-2020 10-K
24 10-30-2019 09-27-2019 10-Q
25 07-31-2019 06-28-2019 10-Q
26 05-01-2019 03-29-2019 10-Q
27 02-21-2019 12-28-2018 10-K
28 10-31-2018 09-28-2018 10-Q
29 08-01-2018 06-29-2018 10-Q
30 05-02-2018 03-30-2018 10-Q
31 02-28-2018 12-29-2017 10-K
32 11-08-2017 09-29-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 03-02-2017 12-30-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-03-2016 07-01-2016 10-Q
38 05-11-2016 04-01-2016 10-Q
39 03-11-2016 01-01-2016 10-K
40 11-04-2015 10-02-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Shareholders Have the Information They Need to Make an Informed VotePreliminary Net Sales Results for Third Quarter Underscore ...

Core News & Articles

Leading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwood's Concerns ...

 staar-surgical-says-that-no-acquisition-proposals-have-been-received-from-any-party-other-than-alcon-alcon-is-paying-staar-stockholders-a-59-premium-to-staars-90-day-volume-weighted-average-price--as-of-august-4-2025-representing-compelling-certain-and-immediate-cash-value

STAAR Surgical Company (NASDAQ:STAA) ("STAAR"), the global leader in phakic IOLs with the EVO family of Implantable Col...

Core News & Articles

Raises Concerns About Whether the Board Fulfilled Its Fiduciary Duty of Care in Doubling Down on Its Commitment to Proposed Tra...

Core News & Articles

Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or th...

Core News & Articles

STAAR Continues to Significantly Underestimate the Strength of the Business and Future Prospects and Misrepresent Its Performan...

Core News & Articles

Contends There Is No Business Justification for the Board's Decision to Sell the Company for $28 Per Share Now After Reject...

Core News & Articles

Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong PriceFor the Reasons Desc...

Core News & Articles

Broadwood Believes the Transaction Comes at the Wrong Time, After the Wrong Process, and at the Wrong PriceFor the Reasons Desc...

Core News & Articles

Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ...

Core News & Articles

Proposed Merger Represents a Compelling 59% Premium to the 90-Day VWAP Prior to AnnouncementSTAAR's Business Risks and Chal...

Core News & Articles

Outlines Its Belief that the Proposed Transaction Is the Product of Bad Timing, a Flawed Process, and Significant Conflicts of ...

Core News & Articles

Reinforces STAAR Board's Determination that Alcon Merger Maximizes Stockholder Value and is Best Path Forward for STAAR Sto...

Core News & Articles

Issues Open Letter to Shareholders Outlining Its Belief that the Proposed Merger Materially Undervalues STAARContends that STAA...

Core News & Articles

Provides Greater Value than STAAR Could Achieve on a Standalone Basis in the Foreseeable Future and is the Best Path Forward fo...

 stifel-downgrades-staar-surgical-to-hold-raises-price-target-to-28

Stifel analyst Thomas Stephan downgrades Staar Surgical (NASDAQ:STAA) from Buy to Hold and raises the price target from $20 ...

 staar-surgical-q2-eps-034-beats-066-estimate-sales-44320m-beat-40674m-estimate

Staar Surgical (NASDAQ:STAA) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.66...

 canaccord-genuity-maintains-hold-on-staar-surgical-raises-price-target-to-28

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and raises the price target from $20 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION